InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

PRECISION BIOSCIENCES INC

DTIL Clue Score48
United States Fiscal year ends May CIK 0001357874
$6.72 +4.51% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.72 −33.33% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 28 Mar 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue10.9Operating income−47.9Net income−46.0Fiscal year 2019Revenue22.2 +104.3%Operating income−87.2Net income−92.9Fiscal year 2020Revenue24.3 +9.2%Operating income−109.8Net income−109.0Fiscal year 2021Revenue115.5 +375.7%Operating income−39.4Net income−30.6EPS, diluted−0.52Fiscal year 2022Revenue25.1 −78.3%Operating income−62.3Net income−111.6EPS, diluted−38.10Fiscal year 2023Revenue48.7 +94.1%Operating income−43.7Net income−61.3EPS, diluted−15.96Fiscal year 2024Revenue68.7 +41.0%Operating income−26.2Net income7.2EPS, diluted1.04Fiscal year 2025Revenue34.3 −50.1%Operating income−52.1Net income−45.7 −738.0%EPS, diluted−3.56
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 10.9 22.2 24.3 115.5 25.1 48.7 68.7 34.3
Growth +104.3% +9.2% +375.7% −78.3% +94.1% +41.0% −50.1%
Operating income −47.9 −87.2 −109.8 −39.4 −62.3 −43.7 −26.2 −52.1
Net income −46.0 −92.9 −109.0 −30.6 −111.6 −61.3 7.2 −45.7
Growth −738.0%
EPS, diluted n/a n/a n/a −0.52 −38.10 −15.96 1.04 −3.56

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Operating margin−440.2%Net margin−423.0%Free cash flow margin−606.5%Fiscal year 2019Operating margin−392.1%Net margin−417.6%Free cash flow margin−430.3%Fiscal year 2020Operating margin−452.2%Net margin−448.9%Free cash flow margin−380.6%Fiscal year 2021Operating margin−34.1%Net margin−26.5%Free cash flow margin−13.8%Fiscal year 2022Operating margin−248.3%Net margin−444.8%Free cash flow margin−195.5%Fiscal year 2023Operating margin−89.8%Net margin−125.8%Free cash flow margin−176.6%Fiscal year 2024Operating margin−38.1%Net margin10.4%Free cash flow margin−85.4%Fiscal year 2025Operating margin−152.2%Net margin−133.4%Free cash flow margin−192.4%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −440.2% −392.1% −452.2% −34.1% −248.3% −89.8% −38.1% −152.2%
Net margin −423.0% −417.6% −448.9% −26.5% −444.8% −125.8% 10.4% −133.4%
Free cash flow margin −606.5% −430.3% −380.6% −13.8% −195.5% −176.6% −85.4% −192.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−51.7Capital expenditure−14.3Free cash flow−66.0Fiscal year 2019Operating cash flow−71.0Capital expenditure−24.7Free cash flow−95.7Fiscal year 2020Operating cash flow−87.4Capital expenditure−5.0Free cash flow−92.4Fiscal year 2021Operating cash flow−10.9Capital expenditure−5.1Free cash flow−15.9Fiscal year 2022Operating cash flow−45.8Capital expenditure−3.3Free cash flow−49.1Fiscal year 2023Operating cash flow−84.1Capital expenditure−2.0Free cash flow−86.1Fiscal year 2024Operating cash flow−58.4Capital expenditure−0.3Free cash flow−58.7Fiscal year 2025Operating cash flow−65.8Capital expenditure−0.1Free cash flow−65.9
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −51.7 −71.0 −87.4 −10.9 −45.8 −84.1 −58.4 −65.8
Capital expenditure −14.3 −24.7 −5.0 −5.1 −3.3 −2.0 −0.3 −0.1
Free cash flow −66.0 −95.7 −92.4 −15.9 −49.1 −86.1 −58.7 −65.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash103.2Shareholders’ equity40.0Fiscal year 2019Cash180.9Shareholders’ equity138.3Fiscal year 2020Cash89.8Shareholders’ equity44.4Fiscal year 2021Cash143.7Total debt2.5Net cash (debt)141.2Shareholders’ equity91.2Debt to equity0.03Fiscal year 2022Cash189.6Total debt22.2Net cash (debt)167.4Shareholders’ equity60.4Debt to equity0.37Fiscal year 2023Cash116.7Shareholders’ equity18.9Fiscal year 2024Cash85.9Shareholders’ equity56.4Fiscal year 2025Cash110.8Shareholders’ equity92.2
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 103.2 180.9 89.8 143.7 189.6 116.7 85.9 110.8
Total debt n/a n/a n/a 2.5 22.2 n/a n/a n/a
Net cash (debt) n/a n/a n/a 141.2 167.4 n/a n/a n/a
Shareholders’ equity 40.0 138.3 44.4 91.2 60.4 18.9 56.4 92.2
Debt to equity n/a n/a n/a 0.03 0.37 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−440.2% −392.1% −452.2% −34.1% −248.3% −89.8% −38.1% −152.2%
n/a n/a n/a n/a n/a n/a 10.4% −133.4%
−423.0% −417.6% −448.9% −26.5% −444.8% −125.8% 10.4% −133.4%
−606.5% −430.3% −380.6% −13.8% −195.5% −176.6% −85.4% −192.4%
Spending
414.6% 370.6% 403.8% 99.7% 183.8% 109.5% 86.7% 158.1%
125.6% 121.5% 148.5% 34.3% 164.5% 80.2% 51.4% 94.1%
131.2% 110.9% 20.7% 4.4% 13.2% 4.0% 0.4% 0.2%
n/a n/a n/a n/a n/a n/a 0.0% n/a
Returns
−115.2% −67.1% −245.4% −33.6% −184.7% −325.1% 12.7% −49.6%
−33.2% −39.5% −72.6% −14.5% −46.9% −38.4% 5.3% −29.6%
Balance and payout
n/a n/a n/a 0.03 0.37 n/a n/a n/a
71.2% 41.2% 70.4% 56.9% 74.6% 88.2% 58.7% 40.3%